“Dr. Matsumoto is a trusted physician leader with a long record of service to the college and a clear commitment to quality, safety and patient-centered care,” ACR CEO Dana H. Smetherman, MD, said May 4.
New findings support the routine use of deep learning-based risk assessments, as this method can decrease subjectivity, reduce unnecessary imaging and improve diagnostic accuracy.
Becoming a father seems to make a man less likely to die young. What’s more, when a father passes away within the first five years of his child’s life, the cause is usually non-natural and thus preventable.
Rad Partners said the addition will help support the company's long-term focus on "physician-led excellence, clinical and technology innovation, and high-quality radiology services at scale."
The American Hospital Association is working with the West Health Institute throughout the duration of the program, which will give health systems access to a digital platform packed full of resources to support technology upgrades.
University of Pittsburgh Medical Center said the deal is expected to be finalized in Fall 2026. The move would expand its presence into Ohio. Details, such as the financial terms, have yet to be revealed.
Last month the Department of Health and Human Services asked hospital dieticians to take an eight-point pledge on inpatient nutrition. This week detractors are firing back at this latest slice of the RFK Jr.-led MAHA agenda.
Legal and compliance teams have to serve as sentinels sizing up potential legal exposure points without turning into needlers who only slow down clinical innovation.
The agency said it is seeking to exclude semaglutide, tirzepatide and liraglutide from the 503B program based on a lack of clinical evidence. Unless there’s a shortage, the pharmaceuticals would be barred from being compounded by third-parties for the purpose of treating diabetes or obesity. The FDA is seeking public comment on the proposal.
“Dr. Matsumoto is a trusted physician leader with a long record of service to the college and a clear commitment to quality, safety and patient-centered care,” ACR CEO Dana H. Smetherman, MD, said May 4.
New findings support the routine use of deep learning-based risk assessments, as this method can decrease subjectivity, reduce unnecessary imaging and improve diagnostic accuracy.
